News & Events

News

TSO3 Announces Closing of US$20 million Financing with Courage Capital to Commercialize the STERIZONE® VP4 Sterilizer and Support Getinge Transition

Myrtle Beach, United States and Quebec City, Canada August 1st, 2018 – TSO3 Inc. (TSX: TOS) (“TSO3” or the “Company”), an innovator in sterilization technology for medical devices, today announced that TSO3 and a fund (the “Fund”) of which Courage Capital Management LLC, (“Courage”) is the investment advisor, have entered into a binding US$20 million debt financing to fund commercialization initiatives for its STERIZONE® VP4 Sterilizer, the only terminal sterilization method that is FDA cleared to sterilize multi-channeled flexible endoscopes (with a maximum of four channels) of up to 3.5 meters in length, such as certain colonoscopes, gastroscopes and duodenoscopes. Courage is a Nashville, TN headquartered alternative asset management firm with a 20-year track record of investments in health care services, medical devices, and pharmaceuticals.

Read more

TSO3 to Report Second Quarter 2018 Results on Wednesday, August 8, 2018

Quebec City, Canada and Myrtle Beach, United States, July 30, 2018 – TSO3 Inc. (TSX: TOS), (“TSO3” or the “Company”), an innovator in sterilization technology for medical devices in healthcare settings, will hold a conference call on Wednesday, August 8, 2018 to discuss its financial results for the second quarter ended June 30, 2018.

Read more

Altru® Health System Improves Patient Care with Expanded Use of Cutting-Edge Sterilization Technology

Grand Forks/Myrtle Beach, United States and Quebec City, Canada – June 14, 2018 – TSO3 Inc. (TSX: TOS) (“TSO3” or the “Company”), an innovator in sterilization technology for medical devices in healthcare settings, joins with Altru® Health System in announcing the landmark U.S. terminal sterilization of long, flexible gastrointestinal endoscopes, like the duodenoscope, using TSO3’s paradigm-shifting STERIZONE® technology.

Read more

TSO3 Announces the Vote Results from its Annual Meeting of the Shareholders and the Appointment New Chairperson

Quebec City, Canada and Myrtle Beach, United States, May 10 2018 – TSO3 Inc. (TSX: TOS), (“TSO3” or the “Company”), an innovator in sterilization technology for medical devices in healthcare settings, today announced that the nominees listed in the management proxy circular dated April 3, 2018, were elected as directors of TSO3. In addition, all other proposals submitted by management were approved.

Read more

TSO3 Obtains New Clearance for the STERIZONE® VP4 Sterilizer

Quebec City, Canada and Myrtle Beach, United States, – May 9, 2018 – TSO3 Inc. (TSX: TOS) (“TSO3” or the “Company”), an innovator in sterilization technology for medical devices in healthcare settings, announced today that it has received clearance from US regulators for its most recent 510(k) submission for the terminal sterilization of multi-channeled flexible endoscopes using the Company’s STERIZONE® VP4 Sterilizer.

Read more

Events